wed08febAll DayHS Nursing School and medication criteria for HS lesions(All Day: wednesday)
All Day (Wednesday)
wed08febAll DayWelcome Addresses(All Day: wednesday)
wed08febAll DayPlenary Session: invited lectures(All Day: wednesday)
Hidradenitis Suppurativa (HS) is a chronic infl ammatory debilitating skin disease with a very heavy impact on quality of life. Until 2006 it has been considered an orphan disease, due to its limited knowledge and also to the great diagnostic delay. An important progress has been made in the last decade concerning its correct and earlier diagnosis and therapeutical approaches. Even though a lot has been done, there is current evidence that the measurements and the therapeutical tools are not able to fulfi l the needs of HS patients. Moreover, it is necessary to increase the centrality of the patient in clinical research to get HS patients involved in their own treatment.
We are glad and proud to welcome you in the city of Florence for the 12th Conference of the European Hidradenitis Suppurativa Foundation and to warmly welcome all the participants via web. This is the city of the Renaissance, a unique period of “rebirth” in arts, culture and science following the Middle Ages. Medicine was the guiding science of the Renaissance. In this period, empirical observation and rational therapy have become the ideals of practice and research in medicine. Paracelsus set the stage for disease causal explanation: “those who only study and treat the effects of the disease are like people who imagine they can wipe out the winter by sweeping the snow on their doorstep. It is not the snow that causes the winter, but the winter that causes the snow”. During the Renaissance, the spreading of new epidemics, the complex relationships between medicine and philosophy, and a new understanding of Galen lead to the advances in the knowledge of anatomy and the modernization of medical research driven by a new approach to science focusing on humans. Indeed, everything was built and thought according to human measure, and our aim is to re-consider the HS patient as part of a human-centered medicine.
Francesca Prignano, MD, PhD
Nicola Pimpinelli, MD, PhD
Professor and Chairman
Prof. Dr. med. Christos C. Zouboulis is Director of the Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Germany, Founding University Professor of Dermatology, Venereology and Allergology at the Brandenburg Medical School Theodor Fontane and Co-opted Professor of Dermatology and Venereology at the Faculty of Health Sciences Brandenburg, Germany.
He is also elected Professeur honoraire at the Medical Faculty, University of Franche-Comté, Besançon, France, Dr. h.c. of the National and Kapodistria University of Athens, Greece, and Visiting Professor of the Shanghai Jiao Tong Medical University, China.
He serves as President of the European Hidradenitis Suppurativa Foundation (EHSF) e.V., Board member of the European Academy of Dermatology and Venereology (EADV) and coordinator of the EADV Task Force on Acne, Rosacea and Hidradenitis Suppurativa (ARHS), Executive Committee Member of the International Society on Behçet’s Disease, President of the Section Saxony-Anhalt of the Federation of German Allergologists, and Honorary President of the European Society of Preventive, Regenerative and Anti-Aging Medicine (ESAAM), and Executive Council member of the Faculty of Health Sciences Brandenburg.
He is currently Editor of EADV News, Co-Editor of “Rejuvenation Research” and member of the Editorial Boards of several leading international scientific journals. He is a honorary member of the French Dermatological Society, the Hungarian Dermatological Society, the Italian Society of Medical, Surgical and Aesthetic Dermatology and Sexually Transmitted Diseases, the Maltese Association of Dermatology and Venereology and the Lithuanian Dermatological Society and was awarded the Medal in Silver by the Wroclaw Medical University, Poland and the Medal of the Rappaport Faculty of Medicine, Technion – Israel Institute of Technology.
He received numerous national and international awards, including the Skin Cancer Prize, the Oskar Gans Prize for Research in Dermatology, the European Dermatology Research Fellowship, the Felix Wankel Animal Protection Research Prize, the “Beauty Care Prize” for excellent Dermatological Research, the “Geroulanos Prize” for History of Medicine, the Paul Gerson Unna Prize on Immunology, the “Liérac Research Award” for Skin Aging Research, the Springer Prize for Dermatology, the Honorary Membership of the patients` charity Deutsche Interessengemeinschaft Akne inversa e.V., and the Open Health Alliance Excellence Award. His Departments have been decorated with the title “Germany land of ideas – place of excellence” for the work on skin stem cells.
Prof. Zouboulis has an extensive publication record with a h-index of 99 (Google Scholar), personal impact factor 2039, and 36000 citations.